JP4898183B2 - Chemical self-injection system - Google Patents

Chemical self-injection system Download PDF

Info

Publication number
JP4898183B2
JP4898183B2 JP2005304595A JP2005304595A JP4898183B2 JP 4898183 B2 JP4898183 B2 JP 4898183B2 JP 2005304595 A JP2005304595 A JP 2005304595A JP 2005304595 A JP2005304595 A JP 2005304595A JP 4898183 B2 JP4898183 B2 JP 4898183B2
Authority
JP
Japan
Prior art keywords
chemical solution
chemical
tube
solution
discharge tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005304595A
Other languages
Japanese (ja)
Other versions
JP2007111179A (en
Inventor
章 吉種
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aubex Corp
Original Assignee
Aubex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aubex Corp filed Critical Aubex Corp
Priority to JP2005304595A priority Critical patent/JP4898183B2/en
Publication of JP2007111179A publication Critical patent/JP2007111179A/en
Application granted granted Critical
Publication of JP4898183B2 publication Critical patent/JP4898183B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、患者自身が薬液を自己の体内に注入するための薬液自己注入器、およびこれを用いた薬液自己注入システムに関する。   The present invention relates to a chemical liquid self-injector for a patient himself to inject a chemical liquid into his or her body, and a chemical liquid self-injection system using the same.

従来、手術等の処置が済んだ後、疼痛を軽減するために患者に対してしばらく鎮痛剤を処方することが多い。通常、カテーテルを用いて、鎮痛剤を含んだ薬液を患者の体内に持続的に注入している。   Conventionally, after treatment such as surgery is completed, an analgesic is often prescribed to a patient for a while to reduce pain. Usually, a drug solution containing an analgesic is continuously infused into a patient's body using a catheter.

しかし、患者の症状や体質は様々であり、当初の処方では、時間の経過と共に激しい痛みを訴える者も少なくない。この場合、痛みを緩和するためには、鎮痛剤の一時的な大量投与が必要となる。そして、このようなときには、医師や看護師を呼ばずとも、患者自身が鎮痛剤を含んだ薬液を一時的に多く体内に注入できれば簡便である。   However, the symptoms and constitutions of patients vary, and many people complain of severe pain over time in the original prescription. In this case, in order to relieve pain, a temporary large-scale administration of an analgesic is required. In such a case, it is convenient if the patient himself / herself can inject a large amount of a drug solution containing an analgesic into the body without calling a doctor or nurse.

そのような薬液自己注入器としては、いくつか例が知られている。例えば、薬液保存瓶とカテーテルの中間部に、薬液収納部と押しボタンを備えた小型の器具を設けて、それを患者の腕にセットできるようにしたものがある(特許文献1)。これによれば、押しボタンを押して、薬液収納部を圧縮すると、中の薬液が患者の体内に注入されるようになっている。また、押しボタンとバネを組合せることで、患者の押す力によらず、ほぼ一定の圧力で薬液を押し出せるようにしたものもある(特許文献2)。さらに、押しボタンを一度押すだけで薬液の注入が自動的に開始され、薬液の注入が終わると自動的に押しボタンが解除されるようになっているものもある(特許文献3)。   Several examples are known as such chemical liquid self-injectors. For example, there is a device in which a small instrument having a chemical solution storage unit and a push button is provided in an intermediate portion between a chemical solution storage bottle and a catheter so that it can be set on a patient's arm (Patent Document 1). According to this, when the push button is pressed to compress the drug solution storage portion, the drug solution therein is injected into the patient's body. In addition, there is a combination of a push button and a spring that can extrude a drug solution with a substantially constant pressure regardless of the force of the patient (Patent Document 2). Furthermore, there is a type in which the injection of the chemical liquid is automatically started by pressing the push button once, and the push button is automatically released when the injection of the chemical liquid is finished (Patent Document 3).

特表昭63−501195号公報JP-T 63-501195 特開平08−308925号公報Japanese Patent Laid-Open No. 08-308925 特開平10−258121号公報JP-A-10-258121

しかしながら、このような従来の薬液自己注入器では、いずれも、薬液保存瓶からカテーテルまでの中間部分に、薬液収納部と一体となった薬液注入器を設けてあるだけであり、通常時は薬液がその薬液収納部を常時通過している。それ故、薬液収納部の構造によっては、薬液の漏れを生じやすい。また、患者の体の動き如何では、薬液が薬液収納部を通過する際に流量が変動するおそれもある。
一方、特許文献3では、自動的に薬液自己注入器の押しボタンが解除されるようになっているが、解除するための回転部が設けてあるなど構造がやや複雑であり、安定動作のためには改良の余地がある。
However, all of these conventional chemical liquid self-injectors only have a chemical liquid injector integrated with the chemical liquid storage section at the intermediate portion from the chemical liquid storage bottle to the catheter. Is always passing through the chemical storage section. Therefore, depending on the structure of the chemical solution storage unit, the chemical solution is likely to leak. Further, depending on the movement of the patient's body, the flow rate may fluctuate when the chemical solution passes through the chemical solution storage unit.
On the other hand, in Patent Document 3, the push button of the chemical liquid self-injector is automatically released, but the structure is somewhat complicated, such as the provision of a rotating part for releasing, for stable operation. There is room for improvement.

そこで本発明は、薬液の追加注入が必要な時に、患者が薬液の自己注入を簡単かつ確実に行うことができ、また、通常の持続注入時においては、薬液収納部からの液漏れがしにくい薬液自己注入器、およびこれを用いた薬液自己注入システムを提供することを目的とする。さらに、本発明は、自己注入操作において、薬液注入の設定が自動的に解除される簡便で確実な機構を有する薬液自己注入器、およびこれを用いた薬液自己注入システムを提供することも目的とする。   Therefore, the present invention enables a patient to easily and reliably perform self-injection of a chemical solution when additional injection of the chemical solution is required, and is difficult to leak from the chemical solution storage unit during normal continuous injection. It is an object of the present invention to provide a chemical liquid self-injector and a chemical liquid self-injection system using the same. Another object of the present invention is to provide a chemical liquid self-injector having a simple and reliable mechanism in which the setting of chemical liquid injection is automatically canceled in the self-injection operation, and a chemical liquid self-injection system using the same. To do.

本発明の薬液自己注入システムは、薬液充填口および薬液排出口を有する薬液収納部と、薬液の追加注入時に前記薬液収納部を加圧変形させ、薬液を押し出す加圧手段と、前記薬液収納部および前記加圧手段を内包する外装ケースとを備え、前記薬液充填口に接続され、前記薬液収納部に薬液を充填するための薬液充填チューブと、前記薬液排出口に接続され、前記追加注入時に前記加圧手段により加圧変形された前記薬液収納部が内部の薬液を排出するための薬液排出チューブと、前記薬液排出チューブの他端で合流部において合流し、薬液を持続的に送るための薬液持続チューブと、前記薬液排出チューブの他端で前記合流部において合流し、前記薬液排出チューブおよび前記薬液持続チューブから流入する薬液を患者に注入するための薬液注入チューブと、前記薬液排出口の近傍で、かつ、前記合流部の手前に位置する挟持部分において、前記薬液排出チューブ内の薬液の流通を制御する挟持手段とを備え、前記挟持手段は、前記薬液排出チューブを挟持するための上部挟持部材と下部挟持部材とを含んで構成されるとともに、前記下部挟持部材を前記上部挟持部材に向かって付勢する挟持用弾性体を有し、前記追加注入時以外には、前記薬液排出チューブは、前記挟持用弾性体の付勢力により加圧される下部挟持部材と、対向する上部挟持部材とで挟持されて断面が閉塞し、前記挟持部分において、内部の薬液が実質的に流動せず、前記追加注入時には、前記加圧手段により前記下部挟持部材が挟持用弾性体の付勢力に抗して押し戻されて前記薬液排出チューブの断面が開き、前記挟持部分において内部の薬液が流動可能となり、前記薬液収納部に充填された薬液が前記薬液排出チューブを通して排出される薬液自己注入器と薬液押出機構を備えた薬液保存容器とを含み、前記薬液押出機構により、前記薬液保存容器に貯蔵された薬液が前記薬液自己注入器に流入するように構成されている薬液自己注入システムであって、前記薬液保存容器に接続された薬液チューブが分岐して前記薬液充填チューブおよび前記薬液持続チューブに接続されていることを特徴とする。 The chemical liquid self-injection system of the present invention includes a chemical liquid storage part having a chemical liquid filling port and a chemical liquid discharge port, pressurizing means for pressurizing and deforming the chemical liquid storage part at the time of additional injection of the chemical liquid, and pushing out the chemical liquid, and the chemical liquid storage part and Bei example the outer casing which encloses said pressing means, connected to the drug solution filling port, and the drug solution filling tube for filling the drug solution into the drug solution housing portion, is connected to the drug solution discharge port, said additional injection Sometimes, the chemical solution storage part pressurized and deformed by the pressurizing means joins the chemical solution discharge tube for discharging the internal chemical solution and the other end of the chemical solution discharge tube at the junction, and continuously sends the chemical solution For injecting into the patient the medicinal solution flowing in from the medicinal solution draining tube and the medicinal solution sustaining tube. A liquid injection tube; and a clamping means for controlling the flow of the chemical liquid in the chemical liquid discharge tube at a clamping portion located in the vicinity of the chemical liquid discharge port and in front of the merging portion, and the clamping means includes: The upper holding member and the lower holding member for holding the chemical solution discharge tube are configured, and includes a holding elastic body for biasing the lower holding member toward the upper holding member, and the additional Other than at the time of injection, the drug solution discharge tube is sandwiched between the lower sandwiching member pressed by the urging force of the sandwiching elastic body and the opposing upper sandwiching member, and the cross-section is closed. The internal chemical liquid does not substantially flow, and at the time of the additional injection, the lower clamping member is pushed back against the urging force of the clamping elastic body by the pressurizing means, and the cross section of the chemical liquid discharge tube is opened. The interior of the drug solution becomes flowable at clamping portion, and a drug solution storage container with a chemical solution filled in the drug solution storage part liquid medicine self-administration device and chemical extrusion mechanism which is discharged through the drug solution discharge tube, wherein A chemical liquid self-injection system configured such that a chemical liquid stored in the chemical liquid storage container flows into the chemical liquid self-injector by a chemical liquid extrusion mechanism, and a chemical liquid tube connected to the chemical liquid storage container branches. Connected to the chemical solution filling tube and the chemical solution sustaining tube .

ここで、追加注入時とは、上述のように、加圧手段により薬液収納部が加圧変形された時をいう。例えば、患者が体の痛みを覚え、押しボタン等の加圧手段を用いて薬液収納部の加圧変形を行った時である。
本発明によれば、薬液自己注入器には、薬液収納部に薬液を充填するための薬液充填チューブと、追加注入時にのみ薬液を排出する薬液排出チューブが接続されており、通常時には、薬液収納部を薬液が通過・流動することがないため、薬液収納部からの液漏れを起こす可能性が少ない。すなわち、追加注入時以外は、薬液持続チューブからの薬液は、合流部を経由して薬液注入チューブに持続的に流れており、薬液収納部には流入しないようになっている。
一方、追加注入時には、上述の加圧手段は、通常時に薬液排出チューブを塞いでいた挟持手段を解除するとともに、薬液収納部内の薬液を薬液排出チューブおよび薬液注入チューブを通して速やかに患者の体内に注入する。すなわち、この加圧手段によれば、必要な時に薬液収納部内の薬液を速やかに患者の体内に注入することができる。
また、本発明の薬液自己注入システムは、上述の薬液自己注入器と、薬液押出機構を備えた薬液保存容器とを含み、前記薬液押出機構により、前記薬液保存容器に貯蔵された薬液が前記薬液自己注入器に流入するように構成されていることを特徴とする。
この薬液押出機構とは、薬液保存容器内部の薬液を常時安定して薬液自己注入器に送るための機構であって、例えば、バルーンが好適に用いられる。バルーンは、薬液を含んで膨らんだ状態の風船状の薬液保存体であり、弱い収縮力を持つ。そのため、内部の薬液を常時安定して薬液自己注入器に送ることができる。その他、例えば、バネを備えた注射器も薬液押出機構として好適である。
Here, the time of additional injection refers to the time when the chemical solution storage part is pressurized and deformed by the pressurizing means as described above. For example, this is when the patient feels pain in the body and uses a pressurizing means such as a push button to deform the medicinal solution storage part under pressure.
According to the present invention, the chemical solution self-injector is connected to the chemical solution filling tube for filling the chemical solution storage part with the chemical solution, and the chemical solution discharge tube for discharging the chemical solution only at the time of additional injection. Since the chemical solution does not pass through or flow through the part, there is little possibility of causing liquid leakage from the chemical solution storage unit. That is, except during the additional injection, the chemical solution from the chemical solution sustaining tube flows continuously to the chemical solution injection tube via the junction, and does not flow into the chemical solution storage unit.
On the other hand, at the time of additional injection, the above-described pressurizing means releases the clamping means that normally closed the chemical solution discharge tube, and quickly injects the chemical solution in the chemical solution storage section into the patient's body through the chemical solution discharge tube and the chemical solution injection tube. To do. That is, according to this pressurizing means, the chemical solution in the chemical solution storage unit can be quickly injected into the patient's body when necessary.
The chemical liquid self-injection system of the present invention includes the above-described chemical liquid self-injector and a chemical liquid storage container having a chemical liquid extrusion mechanism, and the chemical liquid stored in the chemical liquid storage container is stored in the chemical liquid storage container by the chemical liquid extrusion mechanism. It is configured to flow into a self-injector.
This chemical solution extruding mechanism is a mechanism for constantly sending the chemical solution inside the chemical solution storage container to the chemical solution self-injector, and for example, a balloon is preferably used. The balloon is a balloon-shaped chemical solution storage body inflated with a chemical solution, and has a weak contraction force. Therefore, the internal chemical solution can be constantly sent to the chemical solution self-injector. In addition, for example, a syringe provided with a spring is also suitable as the drug solution pushing mechanism.

本発明では、前記加圧手段は、加圧により変形可能なバネ弾性体と、前記バネ弾性体による弾性力を前記薬液収納部に伝達する板状体と、これらを内包して前記外装ケースの内壁に沿って直線状に移動可能な加圧部材とを含んで構成され、前記加圧部材は追加注入時に前記下部挟持部材に当接してこれを押し戻すことのできる張出部を備えていることが好ましい。   In the present invention, the pressurizing means includes a spring elastic body that can be deformed by pressurization, a plate-like body that transmits an elastic force generated by the spring elastic body to the chemical solution storage portion, A pressurizing member that can move linearly along the inner wall, and the pressurizing member has an overhanging portion that can come into contact with and push back the lower clamping member during additional injection. Is preferred.

本発明によれば、加圧手段として、加圧により変形可能なバネ弾性体を用いているので、患者が加圧手段に加える力の如何にかかわらず、バネ弾性体による所定の弾性力により薬液収納部を圧縮するため、薬液収納部から排出される薬液の排出速度を一定の範囲に制限することができる。すわなち、薬液の排出速度が速すぎて薬液チューブが薬液収納部からはずれたり、薬液が漏れたりすることを防止できる。さらに、薬液の注入速度が所定の範囲内であり、速すぎたり遅すぎたりしないため、患者にとっても、肉体上の危険や負担が少ない。   According to the present invention, since the spring elastic body that can be deformed by pressurization is used as the pressurizing means, regardless of the force applied by the patient to the pressurizing means, the medicinal solution is generated by a predetermined elastic force by the spring elastic body. Since the storage portion is compressed, the discharge speed of the chemical solution discharged from the chemical solution storage portion can be limited to a certain range. In other words, it is possible to prevent the chemical solution tube from coming off from the chemical solution storage section and the chemical solution from leaking because the discharge rate of the chemical solution is too fast. Furthermore, since the injection rate of the chemical solution is within a predetermined range and is neither too fast nor too slow, there are few physical risks and burdens for the patient.

また、バネ弾性体と薬液収納部の間には、バネ弾性体による弾性力を薬液収納部に伝達する板状体が介在しているため、バネ弾性体の動きを確実に薬液収納部に伝えることができる。
さらに、この加圧手段は、外装ケースの内壁に沿って直線状に移動可能な加圧部材を有するため、簡易な構成でありながら、確実に薬液収納部を加圧変形することができる。
この加圧部材は、押しボタンとして患者により押し下げられた時に、下部挟持部材に当接してこれを押し戻すことのできる張出部を備えている。それ故、追加注入時には、薬液排出チューブの断面を閉じるように作用していた下部挟持部材の圧力が封じられ、薬液排出チューブの断面が開くことで、薬液収納部内の薬液の排出が可能となる。
In addition, since a plate-like body that transmits the elastic force generated by the spring elastic body to the chemical liquid storage section is interposed between the spring elastic body and the chemical liquid storage section, the movement of the spring elastic body is reliably transmitted to the chemical liquid storage section. be able to.
Furthermore, since this pressurizing means has a pressurizing member that can move linearly along the inner wall of the exterior case, it is possible to reliably pressurize and deform the chemical solution storage portion with a simple configuration.
The pressurizing member includes an overhanging portion that can come into contact with the lower holding member and push it back when it is pushed down by the patient as a push button. Therefore, at the time of additional injection, the pressure of the lower clamping member that has acted to close the cross section of the chemical solution discharge tube is sealed, and the chemical solution in the chemical solution storage section can be discharged by opening the cross section of the chemical solution discharge tube. .

本発明では、前記加圧部材は、面対象あるいは点対象に配置された複数の係合部を備え、前記上部挟持部材は、面対象あるいは点対称に配置された複数の係合突起を備え、前記追加注入時に、前記係合部と前記係合突起とが係合できる構造を有していることが好ましい。   In the present invention, the pressurizing member includes a plurality of engaging portions arranged on a surface object or a point object, and the upper holding member includes a plurality of engaging protrusions arranged on a surface object or in a point symmetry, It is preferable that the engaging portion and the engaging protrusion have a structure that can be engaged during the additional injection.

本発明によれば、加圧手段の加圧部材と、薬液排出チューブを挟持するための上部挟持部材は、相互に係合する係合部と係合突起をそれぞれ有しているため、追加注入時に加圧部材と上部挟持部材とを確実に係合・固定できる。それ故、加圧手段のバネ弾性体を所定の圧縮位置で固定でき、追加注入時に安定して薬液を薬液収納部から排出することが可能となる。
しかも、係合部、および係合突起は各々複数あるとともに、各々の本体部において、面対象あるいは点対称に配置されているため、加圧部材と上部挟持部材との係合がより安定して確実に行われる。
According to the present invention, the pressurizing member of the pressurizing means and the upper clamping member for clamping the chemical solution discharge tube each have the engaging portion and the engaging protrusion that are engaged with each other. Sometimes the pressure member and the upper clamping member can be reliably engaged and fixed. Therefore, the spring elastic body of the pressurizing means can be fixed at a predetermined compression position, and the chemical liquid can be stably discharged from the chemical liquid storage section at the time of additional injection.
In addition, since there are a plurality of engaging portions and engaging protrusions, and each main body portion is arranged in a plane object or point symmetrically, the engagement between the pressure member and the upper clamping member is more stable. Surely done.

本発明では、前記板状体は、前記薬液収納部の加圧変形が終了したときに、前記係合突起に作用して、前記係合部と前記係合突起による係合を解除するための係合解除突起を複数有していることが好ましい。
ここで、薬液収納部の加圧変形が終了したときとは、薬液収納部が前もって定められた変形状態となったときをいう。たとえば、追加注入時における患者への薬液注入量を3ccと決めた場合には、薬液収納部の内容積が3cc減少した状態を意味する。
In the present invention, the plate-like body acts on the engagement protrusion when the pressure deformation of the chemical solution storage part is completed, and releases the engagement by the engagement part and the engagement protrusion. It is preferable to have a plurality of disengagement protrusions.
Here, the time when the pressurizing deformation of the chemical solution storage unit is completed means that the chemical solution storage unit is in a predetermined deformation state. For example, when the amount of the chemical solution injected into the patient at the time of the additional injection is determined to be 3 cc, this means that the internal volume of the chemical solution storage unit is reduced by 3 cc.

本発明によれば、バネ弾性体による弾性力を薬液収納部に伝達する板状体が、上述の係合解除用の突起を有しているため、薬液収納部の加圧変形が終了する時点で、自動的に係合が解除され、バネ弾性体から薬液収納部への弾性力がなくなるため、薬液の排出(患者への薬液追加注入)が停止される。それ故、患者は、押しボタン等の加圧手段を一度起動させるだけで、あとは何らの操作も必要なく、安全確実に薬液の追加注入を行い、終了させることができる。
また、この弾性力がなくなることで、薬液排出チューブは、挟持用弾性体の付勢力により、下部挟持部材と上部挟持部材とで再び挟持されて断面が閉塞する。その結果、薬液は、薬液持続チューブから合流部および薬液注入チューブを通って、再び持続的に患者に流れるようになる。
According to the present invention, the plate-like body that transmits the elastic force of the spring elastic body to the chemical solution storage portion has the above-described disengagement protrusion, and therefore, when the pressure deformation of the chemical solution storage portion ends. Thus, the engagement is automatically released and the elastic force from the spring elastic body to the drug solution storage section is lost, so that the discharge of the drug solution (addition of the drug solution to the patient) is stopped. Therefore, the patient can start the pressurizing means such as a push button once and perform the additional injection of the liquid medicine safely and securely without any further operation, and can finish the operation.
Further, when this elastic force is lost, the chemical solution discharge tube is again held between the lower holding member and the upper holding member by the urging force of the holding elastic body, and the cross section is closed. As a result, the medicinal solution flows from the medicinal solution continuous tube to the patient again through the junction and the medicinal solution injection tube.

以下、本発明の一実施形態を図面に基づいて説明する。
(1)外観構成
図1には、本実施形態に係る薬液自己注入器1と薬液保存容器2とから構成される薬液自己注入システム3を模式的に示した。
薬液自己注入器1は、患者が片手で持てる程度の大きさの外装ケース10、押しボタンを兼ねる加圧部材11、薬液充填チューブ12、薬液注入チューブ13、および、薬液持続チューブ14を備えている。外装ケース10や加圧部材11は、例えばABS等の合成樹脂などで成形されている。
薬液注入チューブ13と薬液持続チューブ14は、外装ケース10の内部で合流し、合流部130から薬液収納部100までは薬液排出チューブ15により接続されている。
Hereinafter, an embodiment of the present invention will be described with reference to the drawings.
(1) External configuration FIG. 1 schematically shows a chemical liquid self-injection system 3 including a chemical liquid self-injector 1 and a chemical liquid storage container 2 according to the present embodiment.
The chemical liquid self-injector 1 includes an exterior case 10 that is large enough for a patient to hold with one hand, a pressurizing member 11 that also serves as a push button, a chemical liquid filling tube 12, a chemical liquid injection tube 13, and a chemical liquid sustaining tube 14. . The outer case 10 and the pressure member 11 are formed of a synthetic resin such as ABS, for example.
The medicinal solution injection tube 13 and the medicinal solution sustaining tube 14 merge inside the outer case 10, and the confluence portion 130 to the medicinal solution storage portion 100 are connected by the medicinal solution discharge tube 15.

薬液保存容器2に接続される1本の薬液チューブ20は、分岐して、コネクタ22により薬液充填チューブ12、および、薬液持続チューブ14に接続される。
薬液保存容器2の内部にはバルーン21が配設されており、バルーン21の内部には所定の薬液が充填されている。バルーン21の材質はエラストマーが好適であり、本実施形態ではシリコーンゴムを用いている。バルーン21の内部の薬液は、このシリコーンゴムの収縮力により、外部に送出されるようになっている。
One chemical liquid tube 20 connected to the chemical liquid storage container 2 branches and is connected to the chemical liquid filling tube 12 and the chemical liquid sustaining tube 14 by a connector 22.
A balloon 21 is disposed inside the chemical solution storage container 2, and the balloon 21 is filled with a predetermined chemical solution. The material of the balloon 21 is preferably an elastomer, and silicone rubber is used in this embodiment. The chemical solution inside the balloon 21 is delivered to the outside by the contraction force of the silicone rubber.

薬液充填チューブ12は、後述する薬液の追加注入が終了した後に薬液収納部100(図2)に薬液を充填するために用いられ、通常時には薬液は流れない。
薬液注入チューブ13は、追加注入時、通常時とも薬液を患者の体内に注入するために用いられ、先端部はカテーテル(図示せず)に接続されている。薬液注入チューブ13の途中には気泡を抜くためのエアベントフィルタ131が設けられている。
薬液持続チューブ14は、通常時に薬液を薬液注入チューブ13を経由して患者の体内に薬液を持続的に注入するために用いられる。なお、薬液持続チューブ14を流れる薬液は、薬液収納部100に流入することなく、合流部130を迂回して薬液注入チューブ13に流入するが詳細は後述する。
The chemical solution filling tube 12 is used to fill the chemical solution storage unit 100 (FIG. 2) after completion of the additional injection of the chemical solution, which will be described later, and normally does not flow.
The drug solution injection tube 13 is used for injecting a drug solution into a patient's body both at the time of additional injection and at normal times, and the distal end portion is connected to a catheter (not shown). An air vent filter 131 for removing air bubbles is provided in the middle of the chemical solution injection tube 13.
The chemical solution continuous tube 14 is used for continuously injecting the chemical solution into the patient's body through the chemical solution injection tube 13 at a normal time. The chemical liquid flowing through the chemical liquid sustaining tube 14 does not flow into the chemical liquid storage unit 100 but flows into the chemical liquid injection tube 13 by bypassing the merging unit 130, which will be described in detail later.

これらの各薬液チューブの材料としては、透明で柔軟性のあるものが好ましく、エラストマーがより好ましい。例えば、ポリオレフィン(LDPE,LLDPE等)系エラストマー、熱可塑性ポリウレタンエラストマー、軟質塩化ビニル樹脂、EVAなどが好適に使用できる。   As a material for each of these chemical solution tubes, a transparent and flexible material is preferable, and an elastomer is more preferable. For example, polyolefin (LDPE, LLDPE, etc.) elastomers, thermoplastic polyurethane elastomers, soft vinyl chloride resins, EVA and the like can be suitably used.

(2)内部構成
図2〜図4は、薬液自己注入器1の内部構成を示す図である。具体的には、図2は、外装ケース10からトップケース10Aをはずして、これらを並べた図である。図3は、外装ケース10内部の本体部分の斜視図である(薬液収納部100と各薬液チューブを外している)。図4は、薬液自己注入器1全体の分解斜視図である。
(2) Internal Configuration FIGS. 2 to 4 are diagrams showing the internal configuration of the chemical liquid self-injector 1. Specifically, FIG. 2 is a diagram in which the top case 10A is removed from the outer case 10 and these are arranged. FIG. 3 is a perspective view of a main body portion inside the exterior case 10 (the chemical solution storage unit 100 and each chemical solution tube are removed). FIG. 4 is an exploded perspective view of the chemical liquid self-injector 1 as a whole.

外装ケース10の内部には、薬液自己注入器1の本体が収容されており、この本体は、薬液収納部100と、薬液収納部100を加圧する加圧手段200と、薬液排出チューブ15を挟持する挟持手段300とを備えて構成される。
外装ケース10を構成するトップケース10A、および、ボトムケース10Bには、各々スリット状の孔10Cが対向して形成されている。このスリット状の孔10Cは、外装ケース10と加圧部材11とが組み合わされたときに、後述する板状体のガイドが挿入されるようになっており、板状体が薬液収納部100を円滑に圧縮できるよう作用する。
The body of the chemical solution self-injector 1 is accommodated in the exterior case 10, and the body sandwiches the chemical solution storage unit 100, the pressurizing means 200 for pressurizing the chemical solution storage unit 100, and the chemical solution discharge tube 15. And clamping means 300.
The top case 10A and the bottom case 10B constituting the exterior case 10 are respectively formed with slit-like holes 10C facing each other. The slit-shaped hole 10 </ b> C is configured such that, when the outer case 10 and the pressure member 11 are combined, a plate-shaped guide described later is inserted. It works so that it can be compressed smoothly.

薬液収納部100は、蛇腹状の構造体であり、内部に所定量の薬液を保持することが可能となっている。この蛇腹状の構造体は軟質の材料により構成されることが好ましい。軟質の材料を用いることにより、薬液収納部100の圧縮・膨張変形を行うことが容易となり、内部への薬液の導入・外部への排出も容易となる。本実施形態では低密度ポリエチレン(LDPE)を用いている。
薬液収納部100には、薬液充填口110と薬液排出口120が形成されている。薬液充填口110には、薬液充填チューブ12が接続され、薬液排出口120には薬液排出チューブ15が接続されている。
薬液排出チューブ15の末端には、合流部130が設けられ、薬液注入チューブ13、および、薬液持続チューブ14が合流している。
The chemical solution storage unit 100 is a bellows-like structure and can hold a predetermined amount of chemical solution therein. This bellows-like structure is preferably made of a soft material. By using a soft material, it becomes easy to compress and expand the chemical solution storage unit 100, and it is easy to introduce and discharge the chemical solution to the inside. In this embodiment, low density polyethylene (LDPE) is used.
The chemical solution storage unit 100 is formed with a chemical solution filling port 110 and a chemical solution discharge port 120. The chemical solution filling tube 12 is connected to the chemical solution filling port 110, and the chemical solution discharge tube 15 is connected to the chemical solution discharge port 120.
A junction 130 is provided at the end of the chemical solution discharge tube 15, and the chemical solution injection tube 13 and the chemical solution sustaining tube 14 are joined.

加圧手段200は、押しボタンを兼ねる頭部を持った円筒状の加圧部材11と、薬液収納部100に密着する円板状の板状体220と、この板状体220を弾性力で加圧するバネ弾性体230とを含んで構成される。
加圧部材11は、外装ケース10から若干外部に突出しており、頭部はフラットになっている。この頭部はあまり外装ケース10から突き出ないように構成されている。つまり、患者がこの加圧部材(押しボタン)11を押すと、加圧部材11は、外装ケース10の内壁に沿って直線状に移動するが、外装ケース10の内部まで押し込まなければ、後述の上部挟持部材との係合はできないようになっている。患者がうっかりボタンにふれた程度で薬液が急に追加注入される危険を防ぐためである。
The pressurizing means 200 includes a cylindrical pressurizing member 11 having a head that also serves as a push button, a disc-like plate-like body 220 that is in close contact with the chemical solution storage unit 100, and the plate-like body 220 by elastic force. And a spring elastic body 230 to be pressurized.
The pressure member 11 slightly protrudes from the outer case 10 and has a flat head. The head is configured not to protrude from the exterior case 10 so much. That is, when the patient presses the pressurizing member (push button) 11, the pressurizing member 11 moves linearly along the inner wall of the outer case 10. The upper clamping member cannot be engaged. This is in order to prevent the risk that a chemical solution is suddenly injected as soon as the patient inadvertently touches the button.

加圧部材11の側壁には、長方形状の2つの開口212(図3)が対向して形成されている。また、この側壁には2つのスリット213が同様に対向して形成されている。これらの開口212とスリット213とは、90度ずれた位置に形成されている。
開口212の4辺のうち、下部の1辺は後述の上部挟持部材と係合する係合部212Aとして作用する。
また、加圧部材11には、スリット213を介して二股に別れた一対の張出部210が2つ対向して設けられている。この張出部210は、加圧部材11が押されたときに、後述する下部挟持部材を押し下げるように作用する。
Two rectangular openings 212 (FIG. 3) are formed on the side wall of the pressure member 11 so as to face each other. In addition, two slits 213 are similarly formed on the side wall so as to face each other. These openings 212 and slits 213 are formed at positions shifted by 90 degrees.
Of the four sides of the opening 212, one lower side acts as an engaging portion 212A that engages with an upper clamping member described later.
In addition, the pressure member 11 is provided with two pairs of overhanging portions 210 that are separated into two forks via a slit 213. The overhanging portion 210 acts to push down a lower clamping member, which will be described later, when the pressure member 11 is pressed.

板状体220の外周には、断面が長方形状のガイド222が2つ設けられ、このガイド222は、前述のスリット213を突き抜けてさらに外装ケース10の側壁に設けられたスリット状の孔10Cにも挿入されるようになっている。
また、板状体220は、2個の係合解除突起221を備えており、この係合解除突起221は、薬液収納部100が加圧により縮小変形するとともに移動し、後述の係合突起を広げて、係合部212Aと係合突起による係合を解除するように作用する。
Two guides 222 having a rectangular cross section are provided on the outer periphery of the plate-like body 220, and the guides 222 penetrate through the slits 213 described above and further enter slit-like holes 10 </ b> C provided on the side walls of the exterior case 10. Also comes to be inserted.
The plate-like body 220 includes two disengagement protrusions 221. The disengagement protrusions 221 move as the chemical solution storage unit 100 is deformed and contracted by pressurization. It spreads and acts to release the engagement by the engaging portion 212A and the engaging protrusion.

バネ弾性体230は、加圧部材11が押されたときに圧縮変形され、その弾性力を板状体220を介して、薬液収納部100に伝える。   The spring elastic body 230 is compressed and deformed when the pressing member 11 is pressed, and transmits the elastic force to the chemical solution storage unit 100 via the plate-like body 220.

挟持手段300は、薬液排出チューブ15を挟持するための上部挟持部材310と下部挟持部材320とから構成されるとともに、下部挟持部材320を上部挟持部材に向かって付勢する弁バネ(挟持用弾性体)330が装着されている。この弁バネ330は、下端当接部材10Dに接している。
上部挟持部材310は、両端が略90度同一方向に曲げられた扁平角柱状の構造をしており、外装ケース10内で固定されている。それ故、バネ弾性体230等による力を受けても移動しないようになっている。また、上部挟持部材310の両端には、開口212の係合部212Aと係合するための係合突起311が各々設けられている。これら2つの係合突起311は、本体である上部挟持部材310において面対称に配設されている。
薬液の追加注入時には、この係合部212Aと係合突起311とが係合することで、加圧部材11の内部にあるバネ弾性体230・板状体220が安定して薬液収納部100を圧縮できるようになる。
The clamping means 300 is composed of an upper clamping member 310 and a lower clamping member 320 for clamping the chemical liquid discharge tube 15, and a valve spring (a clamping elasticity) that biases the lower clamping member 320 toward the upper clamping member. Body) 330 is mounted. The valve spring 330 is in contact with the lower end contact member 10D.
The upper clamping member 310 has a flat prismatic structure in which both ends are bent in the same direction by approximately 90 degrees, and is fixed in the outer case 10. Therefore, it does not move even if it receives a force from the spring elastic body 230 or the like. Engaging protrusions 311 for engaging with the engaging portion 212A of the opening 212 are provided at both ends of the upper clamping member 310, respectively. These two engaging protrusions 311 are arranged in plane symmetry in the upper holding member 310 which is a main body.
At the time of the additional injection of the chemical solution, the engagement portion 212A and the engagement protrusion 311 are engaged with each other, so that the spring elastic body 230 and the plate-like body 220 inside the pressurizing member 11 stably stabilize the chemical solution storage portion 100. It can be compressed.

下部挟持部材320は、上部挟持部材310と弁バネ330の間に位置し、外装ケース10の長手方向に若干移動できるようになっている。ここで、弁バネ330は、下端当接部材10Dと下部挟持部材320とで常時圧縮されており、下部挟持部材320を付勢力にて押し上げるように作用する。それ故、追加注入時以外には、薬液排出チューブ15は、弁バネ330の付勢力により押圧される下部挟持部材320と、対向する上部挟持部材310とで挟持されて断面が閉じ、この挟持部分340において、内部の薬液の流動はできないようになっている。
一方、追加注入時には、加圧部材11の張出部210により下部挟持部材320が押し戻されて薬液排出チューブ15の断面が開き、挟持部分340において内部の薬液が流動可能となり、薬液収納部100に充填された薬液が薬液排出チューブ15を通して排出される。
The lower clamping member 320 is positioned between the upper clamping member 310 and the valve spring 330 and can move slightly in the longitudinal direction of the outer case 10. Here, the valve spring 330 is always compressed by the lower end abutting member 10D and the lower clamping member 320, and acts to push up the lower clamping member 320 with an urging force. Therefore, except at the time of additional injection, the chemical solution discharge tube 15 is sandwiched between the lower clamping member 320 pressed by the urging force of the valve spring 330 and the opposing upper clamping member 310 to close the cross section. In 340, the internal chemical liquid cannot flow.
On the other hand, at the time of additional injection, the lower clamping member 320 is pushed back by the overhanging portion 210 of the pressurizing member 11 to open the cross section of the chemical solution discharge tube 15, and the internal chemical solution can flow in the clamping portion 340, The filled chemical liquid is discharged through the chemical liquid discharge tube 15.

(3)薬液自己注入器1の動作
以下に、図5〜図10をもとにして、本実施形態における薬液自己注入器1の動作を具体的に説明する。各図とも、動作中の薬液自己注入器1を側面から見た断面図であり、(A)と(B)は、各々視点を90度ずらしたものである。
(3) Operation of the chemical liquid self-injector 1 The operation of the chemical liquid self-injector 1 according to the present embodiment will be specifically described below with reference to FIGS. Each figure is a cross-sectional view of the chemical self-injector 1 in operation as viewed from the side, and (A) and (B) are obtained by shifting the viewpoint by 90 degrees.

図5は、いわゆる通常時における薬液自己注入器1を示した図である。
薬液保存容器2(図1)から送られてきた薬液は薬液持続チューブ14を通り、合流部130を経由して薬液注入チューブ13に流れている。薬液注入チューブ13はカテーテル(図示せず)に接続され、患者の体内には常時薬液が流れている。
薬液排出口120近傍に位置する挟持部分340では、薬液排出チューブ15は、上部挟持部材310、および、下部挟持部材320に挟持されている。弁バネ(挟持用弾性体)330の付勢力により下部挟持部材320は常時押し上げられており、薬液排出チューブ15は、挟持部分340で閉じられている。
FIG. 5 is a view showing the chemical liquid self-injector 1 at a so-called normal time.
The chemical solution sent from the chemical solution storage container 2 (FIG. 1) flows through the chemical solution sustaining tube 14 and flows into the chemical solution injection tube 13 via the junction 130. The medicinal solution injection tube 13 is connected to a catheter (not shown), and the medicinal solution always flows in the patient's body.
In the clamping part 340 located in the vicinity of the chemical liquid discharge port 120, the chemical liquid discharge tube 15 is clamped by the upper clamping member 310 and the lower clamping member 320. The lower clamping member 320 is always pushed up by the urging force of the valve spring (clamping elastic body) 330, and the chemical solution discharge tube 15 is closed by the clamping part 340.

図6は、患者が、押しボタンである加圧部材11を押し込んだ追加注入時の状態を示している。
加圧部材11は、押し込まれると、加圧部材11の両側壁にある開口212の下部に形成された係合部212Aが、上部挟持部材310の両端に形成された係合突起311と係合する。
一方、加圧部材11の張出部210は、下部挟持部材320に当接しながらこれを押し戻し、薬液排出チューブ15を挟持する付勢力を付与していた弁バネ(挟持用弾性体)330の作用を封じる。その結果、薬液排出チューブ15が挟持部分340で開口し、薬液収納部100内の薬液が排出可能となる。
FIG. 6 shows a state at the time of additional injection in which the patient pushes the pressing member 11 as a push button.
When the pressing member 11 is pushed in, the engaging portions 212A formed at the lower portions of the openings 212 on both side walls of the pressing member 11 are engaged with the engaging protrusions 311 formed at both ends of the upper holding member 310. To do.
On the other hand, the overhanging portion 210 of the pressurizing member 11 is pushed back while abutting against the lower clamping member 320, and the action of the valve spring (holding elastic body) 330 to which the biasing force for clamping the chemical solution discharge tube 15 is applied. To seal. As a result, the chemical solution discharge tube 15 opens at the clamping portion 340, and the chemical solution in the chemical solution storage unit 100 can be discharged.

図7は、バネ弾性体230の弾性力により、板状体220を介して薬液収納部100が圧縮されていく状態を示した図である。
この段階では、薬液収納部100内の薬液が、薬液排出口120、合流部130を経由して薬液注入チューブ13内に急速に流入する。そして、患者の体内には、通常時の薬液流入量を上回る量の薬液が短時間で注入される。
なお、薬液充填チューブ12、および薬液持続チューブ14は内部抵抗が高く、また、バルーン21(図1)の圧力もあって、逆流は事実上起こらないようになっている。もちろん、これらに逆止弁が設けてあってもよい。
FIG. 7 is a view showing a state where the chemical solution storage unit 100 is compressed through the plate-like body 220 by the elastic force of the spring elastic body 230.
At this stage, the chemical solution in the chemical solution storage unit 100 rapidly flows into the chemical solution injection tube 13 via the chemical solution discharge port 120 and the junction 130. And a chemical | medical solution of the quantity exceeding the normal chemical | medical solution inflow amount is inject | poured in a patient's body in a short time.
The chemical solution filling tube 12 and the chemical solution sustaining tube 14 have high internal resistance, and the pressure of the balloon 21 (FIG. 1) is also present, so that the backflow does not occur in practice. Of course, these may be provided with a check valve.

図8は、薬液収納部100の圧縮が終了間際となった状態であり、降下しつつある板状体220に設けられた係合解除突起221が、上部挟持部材310の両端に位置する係合突起311を広げていく様子を示している(図8B)。   FIG. 8 shows a state in which the compression of the chemical solution storage unit 100 is almost finished, and the disengagement protrusions 221 provided on the plate-like body 220 that is descending are engaged at both ends of the upper holding member 310. A state in which the protrusion 311 is expanded is shown (FIG. 8B).

図9は、この係合解除突起221が、係合突起311を広げきった結果、加圧部材11と、上部挟持部材310との係合が解除された瞬間を示している。この係合解除により、加圧部材11はフリーな状態となって、内部のバネ弾性体230に加えていた圧力もなくなるため、薬液収納部100からの薬液排出は停止する。
同時に、弁バネ330を抑えていた加圧部材11(張出部210)は、逆に、弁バネ330の付勢力により跳ね上げられる。
同時に、薬液排出チューブ15は、この弁バネ330の付勢力を受けた下部挟持部材320により再び閉じられる。
FIG. 9 shows the moment when the engagement between the pressurizing member 11 and the upper clamping member 310 is released as a result of the engagement releasing projection 221 fully expanding the engaging projection 311. Due to this disengagement, the pressurizing member 11 is in a free state, and the pressure applied to the internal spring elastic body 230 is eliminated, so that the discharge of the chemical solution from the chemical solution storage unit 100 is stopped.
At the same time, the pressure member 11 (the overhanging portion 210) that has suppressed the valve spring 330 is flipped up by the urging force of the valve spring 330.
At the same time, the chemical solution discharge tube 15 is closed again by the lower clamping member 320 that receives the urging force of the valve spring 330.

図10は、薬液充填チューブ12を経由して薬液収納部100内に薬液が充填されていく様子を示している。
なお、薬液充填中であっても、薬液持続チューブ14から合流部130を経由して薬液注入チューブ13内に薬液が流入しているのは、図5の場合と同様である。
FIG. 10 shows a state in which the chemical solution is filled into the chemical solution storage unit 100 via the chemical solution filling tube 12.
Even during the filling of the chemical solution, the chemical solution flows into the chemical solution injection tube 13 from the chemical solution sustaining tube 14 via the junction 130 as in the case of FIG.

上述のような本実施形態によれば、次のような効果がある。
(1)追加注入時以外は、薬液持続チューブ14からの薬液は、合流部130を経由して薬液注入チューブ13に持続的に流れており、薬液収納部100には流入しないようになっている。すなわち、薬液収納部100を薬液が通過・流動することがないため、薬液収納部100からの液漏れを起こす可能性が少ない。
一方、追加注入時には、薬液排出チューブ15を塞いでいた挟持手段300が解除されるとともに、薬液収納部100内の薬液を薬液排出チューブ15、および薬液注入チューブ13を通して速やかに患者の体内に注入できる。
According to this embodiment as described above, the following effects are obtained.
(1) Except at the time of additional injection, the chemical solution from the chemical solution continuous tube 14 continuously flows into the chemical solution injection tube 13 via the merging unit 130 and does not flow into the chemical solution storage unit 100. . That is, since the chemical solution does not pass through or flows through the chemical solution storage unit 100, there is little possibility of liquid leakage from the chemical solution storage unit 100.
On the other hand, at the time of additional injection, the clamping means 300 that has blocked the chemical solution discharge tube 15 is released, and the chemical solution in the chemical solution storage unit 100 can be quickly injected into the patient's body through the chemical solution discharge tube 15 and the chemical solution injection tube 13. .

(2)加圧手段200として、加圧により変形可能なバネ弾性体230を用いているので、患者が加圧手段200に加える力の如何にかかわらず、バネ弾性体230による所定の弾性力により薬液収納部100を圧縮するため、薬液収納部100から排出される薬液の排出速度を一定の範囲に制限することができる。すわなち、薬液の排出速度が速すぎて薬液排出チューブ15が薬液収納部100からはずれたり、薬液が漏れたりすることを防止できる。さらに、薬液の注入速度が所定の範囲内であり、速すぎたり遅すぎたりしないため、患者にとっても、肉体上の危険や負担が少ない。 (2) Since the spring elastic body 230 that can be deformed by pressurization is used as the pressurizing means 200, regardless of the force applied by the patient to the pressurizing means 200, a predetermined elastic force by the spring elastic body 230 is used. Since the chemical solution storage unit 100 is compressed, the discharge rate of the chemical solution discharged from the chemical solution storage unit 100 can be limited to a certain range. In other words, it is possible to prevent the chemical solution discharge speed from being excessively high and the chemical solution discharge tube 15 from being detached from the chemical solution storage unit 100 or from leaking the chemical solution. Furthermore, since the injection rate of the chemical solution is within a predetermined range and is neither too fast nor too slow, there are few physical risks and burdens for the patient.

(3)バネ弾性体230と薬液収納部100との間には、バネ弾性体230による弾性力を薬液収納部100に伝達する板状体220が介在しているため、バネ弾性体230の弾性力を確実に薬液収納部100に伝えることができる。 (3) Since the plate-like body 220 that transmits the elastic force generated by the spring elastic body 230 to the chemical liquid storage section 100 is interposed between the spring elastic body 230 and the chemical liquid storage section 100, the elasticity of the spring elastic body 230 is reduced. The force can be reliably transmitted to the chemical solution storage unit 100.

(4)加圧手段200は、外装ケース10の内壁に沿って直線状に移動可能な加圧部材11を有するため、簡易な構成でありながら、確実に薬液収納部100を加圧変形することができる。
この加圧部材11は、押しボタンとして患者により押し下げられた追加注入時に、下部挟持部材320に当接してこれを押し戻すことのできる張出部210を備えている。それ故、追加注入時には、薬液排出チューブ15の断面を閉じるように作用していた下部挟持部材320の圧力が封じられ、薬液排出チューブ15の断面が開くことで、薬液収納部内の薬液の排出が可能となる。
(4) Since the pressurizing means 200 includes the pressurizing member 11 that can move linearly along the inner wall of the outer case 10, it is possible to reliably pressurize and deform the chemical solution storage unit 100 with a simple configuration. Can do.
The pressurizing member 11 includes an overhanging portion 210 that can come into contact with the lower holding member 320 and push it back at the time of additional injection pushed down by the patient as a push button. Therefore, at the time of additional injection, the pressure of the lower clamping member 320 that has acted to close the cross section of the chemical liquid discharge tube 15 is sealed, and the chemical liquid is discharged from the chemical liquid storage section by opening the cross section of the chemical liquid discharge tube 15. It becomes possible.

(5)薬液収納部100は、軟質の低密度ポリエチレン(LDPE)を用いて構成されているので、薬液収納部100の圧縮・膨張変形を行うことが容易となり、内部への薬液の導入・外部への排出も容易となる。薬液収納部100の剛性が高いと、薬液収納部100自体が薬液を吸引する力を持つようになり、薬液充填時間が短くなりすぎて好ましくない。 (5) Since the chemical solution storage unit 100 is configured using soft low-density polyethylene (LDPE), it is easy to compress and expand the chemical solution storage unit 100, and the chemical solution is introduced into the inside / outside. It is easy to discharge. When the rigidity of the chemical solution storage unit 100 is high, the chemical solution storage unit 100 itself has a force to suck the chemical solution, which is not preferable because the filling time of the chemical solution becomes too short.

(6)加圧手段200の加圧部材11と、薬液排出チューブ15を挟持するための上部挟持部材310は、相互に係合する係合部212Aと係合突起311をそれぞれ有しているため、追加注入時に加圧部材11と上部挟持部材310とを確実に係合・固定できる。それ故、加圧手段200のバネ弾性体230を所定の圧縮位置で固定でき、追加注入時に安定して薬液を薬液収納部100から排出することが可能となる。
しかも、係合部212A、および係合突起311は各々複数あるとともに、各々の本体部において、面対称に配置されているため、加圧部材11と上部挟持部材310との係合がより安定して確実に行われる。
(6) The pressurizing member 11 of the pressurizing means 200 and the upper sandwiching member 310 for sandwiching the chemical solution discharge tube 15 each have an engaging portion 212A and an engaging projection 311 that engage with each other. The pressurizing member 11 and the upper clamping member 310 can be reliably engaged and fixed at the time of additional injection. Therefore, the spring elastic body 230 of the pressurizing means 200 can be fixed at a predetermined compression position, and the chemical solution can be discharged from the chemical solution storage unit 100 stably at the time of additional injection.
Moreover, since there are a plurality of engaging portions 212A and engaging protrusions 311 and the main body portions are arranged in plane symmetry, the engagement between the pressure member 11 and the upper clamping member 310 is more stable. Surely done.

(7)バネ弾性体230による弾性力を薬液収納部100に伝達する板状体220が、係合解除突起221を有しているため、薬液収納部100の加圧変形が終了する時点で、自動的に係合が解除され、バネ弾性体230から薬液収納部100への弾性力がなくなるため、薬液の排出(患者への薬液追加注入)が停止される。それ故、患者は、加圧手段(押しボタン)200を一度押すだけで、あとは何らの操作も必要なく、安全確実に薬液の追加注入を行い、終了させることができる。
特に、係合解除突起221の動きは直線的であり、回転等の複雑な動作を伴わないので、確実に係合を解除することができる。
(7) Since the plate-like body 220 that transmits the elastic force generated by the spring elastic body 230 to the chemical solution storage unit 100 has the engagement release protrusion 221, when the pressure deformation of the chemical solution storage unit 100 ends, Since the engagement is automatically released and the elastic force from the spring elastic body 230 to the drug solution storage unit 100 is lost, the discharge of the drug solution (addition of the drug solution to the patient) is stopped. Therefore, the patient can press the pressurizing means (push button) 200 once and perform the additional injection of the chemical solution safely and without any further operation, and can be terminated.
Particularly, the movement of the disengagement protrusion 221 is linear and does not involve a complicated operation such as rotation, so that the engagement can be reliably released.

(8)板状体220は、外周にガイド222を有しており、加圧部材11のスリット213や外装ケース10のスリット状の孔に挿入された状態で移動するため、薬液収納部100の圧縮が円滑に行われる。また、外装ケース10の外部から板状体220の位置が確認できるため、薬液の追加注入の度合いが容易に確認できる。 (8) The plate-like body 220 has a guide 222 on the outer periphery, and moves while being inserted into the slit 213 of the pressurizing member 11 or the slit-like hole of the outer case 10. Compression is performed smoothly. Moreover, since the position of the plate-like body 220 can be confirmed from the outside of the exterior case 10, the degree of additional injection of the chemical solution can be easily confirmed.

本発明を実施するための最良の構成などは、以上の記載で開示されているが、本発明は、これに限定されるものではない。すなわち、本発明は、主に特定の実施形態に関して特に図示され、かつ、説明されているが、本発明の技術的思想および目的の範囲から逸脱することなく、以上述べた実施形態に対し、形状、材質、数量、その他の詳細な構成において、当業者が様々な変形を加えることができるものである。   Although the best configuration for carrying out the present invention has been disclosed in the above description, the present invention is not limited to this. That is, the invention has been illustrated and described primarily with respect to particular embodiments, but may be configured for the above-described embodiments without departing from the scope and spirit of the invention. Various modifications can be made by those skilled in the art in terms of materials, quantity, and other detailed configurations.

したがって、上記に開示した形状、材質などを限定した記載は、本発明の理解を容易に
するために例示的に記載したものであり、本発明を限定するものではないから、それらの
形状、材質などの限定の一部若しくは全部の限定を外した部材の名称での記載は、本発明
に含まれるものである。
Therefore, the description limited to the shape, material, etc. disclosed above is an example for easy understanding of the present invention, and does not limit the present invention. The description by the name of the member which remove | excluded the limitation of one part or all of such is included in this invention.

例えば、前記実施形態では、薬液収納部100として、蛇腹状の容器を採用していたが、本発明はこれに限られず、柔軟で可撓性に富んだ樹脂製の袋を用いてもよい。
また、薬液保存容器2から伸びた薬液チューブ20や薬液充填チューブ12には、流量制御用の弁を設けてもよい。
さらにまた、前記実施形態では、薬液押出機構としてバルーンを用いたが、バルーンのかわりにバネを備えた注射器を用いてもよい。
For example, in the above embodiment, a bellows-like container is employed as the chemical solution storage unit 100. However, the present invention is not limited to this, and a soft and flexible resin bag may be used.
The chemical solution tube 20 and the chemical solution filling tube 12 extending from the chemical solution storage container 2 may be provided with a valve for controlling the flow rate.
Furthermore, in the above-described embodiment, a balloon is used as the chemical solution extruding mechanism, but a syringe equipped with a spring may be used instead of the balloon.

本発明は、必要な時に患者が薬液の自己注入を簡単かつ確実に行うことができる薬液自己注入器として利用できる。   INDUSTRIAL APPLICABILITY The present invention can be used as a chemical solution self-injector that allows a patient to simply and reliably perform self-injection of a chemical solution when necessary.

本発明の実施形態に係る薬液自己注入システムを示す模式図。The schematic diagram which shows the chemical | medical solution self-injection system which concerns on embodiment of this invention. 前記実施形態における薬液自己注入器の内部を示す側面図。The side view which shows the inside of the chemical | medical solution self-injector in the said embodiment. 前記実施形態における薬液自己注入器内部の主要部分を示す斜視図。The perspective view which shows the principal part inside the chemical | medical solution self-injector in the said embodiment. 前記実施形態における薬液自己注入器の分解斜視図。The disassembled perspective view of the chemical | medical solution self-injector in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment. 前記実施形態における薬液排出・充填動作を示す断面図。Sectional drawing which shows the chemical | medical solution discharge | emission and filling operation | movement in the said embodiment.

符号の説明Explanation of symbols

1・・・薬液自己注入器
2・・・薬液保存容器
3・・・薬液自己注入システム
10・・・外装ケース
11・・・加圧部材
12・・・薬液充填チューブ
13・・・薬液注入チューブ
14・・・薬液持続チューブ
15・・・薬液排出チューブ
100・・・薬液収納部
200・・・加圧手段
220・・・板状体
230・・・バネ弾性体
310・・・上部挟持部材
320・・・下部挟持部材
330・・・弁バネ(挟持用弾性体)
DESCRIPTION OF SYMBOLS 1 ... Chemical liquid self-injector 2 ... Chemical liquid storage container 3 ... Chemical liquid self-injection system 10 ... Outer case 11 ... Pressurizing member 12 ... Chemical liquid filling tube 13 ... Chemical liquid injection tube 14 ... Chemical solution sustaining tube 15 ... Chemical solution discharge tube 100 ... Chemical solution storage part 200 ... Pressurizing means 220 ... Plate-like body 230 ... Spring elastic body 310 ... Upper clamping member 320 ... Lower clamping member 330 ... Valve spring (elastic body for clamping)

Claims (4)

薬液充填口および薬液排出口を有する薬液収納部と、薬液の追加注入時に前記薬液収納部を加圧変形させ、薬液を押し出す加圧手段と、前記薬液収納部および前記加圧手段を内包する外装ケースとを備え、
前記薬液充填口に接続され、前記薬液収納部に薬液を充填するための薬液充填チューブと、
前記薬液排出口に接続され、前記追加注入時に前記加圧手段により加圧変形された前記薬液収納部が内部の薬液を排出するための薬液排出チューブと、
前記薬液排出チューブの他端で合流部において合流し、薬液を持続的に送るための薬液持続チューブと、
前記薬液排出チューブの他端で前記合流部において合流し、前記薬液排出チューブおよび前記薬液持続チューブから流入する薬液を患者に注入するための薬液注入チューブと、
前記薬液排出口の近傍で、かつ、前記合流部の手前に位置する挟持部分において、前記薬液排出チューブ内の薬液の流通を制御する挟持手段とを備え、
前記挟持手段は、前記薬液排出チューブを挟持するための上部挟持部材と下部挟持部材とを含んで構成されるとともに、前記下部挟持部材を前記上部挟持部材に向かって付勢する挟持用弾性体を有し、
前記追加注入時以外には、前記薬液排出チューブは、前記挟持用弾性体の付勢力により加圧される下部挟持部材と、対向する上部挟持部材とで挟持されて断面が閉塞し、前記挟持部分において、内部の薬液が実質的に流動せず、
前記追加注入時には、前記加圧手段により前記下部挟持部材が挟持用弾性体の付勢力に抗して押し戻されて前記薬液排出チューブの断面が開き、前記挟持部分において内部の薬液が流動可能となり、前記薬液収納部に充填された薬液が前記薬液排出チューブを通して排出される薬液自己注入器
薬液押出機構を備えた薬液保存容器とを含み、前記薬液押出機構により、前記薬液保存容器に貯蔵された薬液が前記薬液自己注入器に流入するように構成されている薬液自己注入システムであって、
前記薬液保存容器に接続された薬液チューブが分岐して前記薬液充填チューブおよび前記薬液持続チューブに接続されている
ことを特徴とする薬液自己注入システム。
A chemical solution storage unit having a chemical solution filling port and a chemical solution discharge port, a pressurizing unit that pressurizes and deforms the chemical solution storage unit when a chemical solution is additionally injected, and pushes out the chemical solution, and an exterior housing the chemical solution storage unit and the pressurizing unit Bei example the case,
A chemical solution filling tube connected to the chemical solution filling port for filling the chemical solution storage section with the chemical solution;
A chemical solution discharge tube connected to the chemical solution discharge port, for discharging the chemical solution inside the chemical solution storage section that is pressurized and deformed by the pressurizing means at the time of the additional injection;
A chemical solution continuous tube for joining the chemical solution discharge tube at the other end of the chemical solution discharge tube and continuously sending the chemical solution;
A medicinal solution injection tube for injecting medicinal solution flowing from the medicinal solution discharge tube and the medicinal solution sustaining tube into the patient at the other end of the medicinal solution discharge tube,
In the clamping portion located in the vicinity of the chemical solution discharge port and before the merge portion, the holding means for controlling the flow of the chemical solution in the chemical solution discharge tube,
The clamping means includes an upper clamping member and a lower clamping member for clamping the chemical solution discharge tube, and a clamping elastic body for biasing the lower clamping member toward the upper clamping member. Have
Except at the time of the additional injection, the chemical solution discharge tube is sandwiched between the lower sandwiching member pressed by the urging force of the sandwiching elastic body and the opposing upper sandwiching member to close the cross section, and the sandwiching portion In, the internal chemicals do not flow substantially,
At the time of the additional injection, the lower clamping member is pushed back against the urging force of the clamping elastic body by the pressurizing means to open the cross section of the chemical solution discharge tube, and the internal chemical solution can flow in the clamping portion, and discharged Ru drug solution autoinjector through chemical solution filled in the drug solution housing part is the drug solution discharge tube
A chemical solution self-injection system configured to allow a chemical solution stored in the chemical solution storage container to flow into the chemical solution self-injector by the chemical solution extrusion mechanism. ,
A chemical solution tube connected to the chemical solution storage container is branched and connected to the chemical solution filling tube and the chemical solution sustaining tube.
This is a chemical liquid self-injection system.
請求項1に記載の薬液自己注入システムにおいて、
前記加圧手段は、加圧により変形可能なバネ弾性体と、前記バネ弾性体による弾性力を前記薬液収納部に伝達する板状体と、これらを内包して前記外装ケースの内壁に沿って直線状に移動可能な加圧部材とを含んで構成され、
前記加圧部材は、前記追加注入時に前記下部挟持部材に当接してこれを押し戻すことのできる張出部を備えていることを特徴とする薬液自己注入システム
The chemical liquid self-injection system according to claim 1,
The pressurizing means includes a spring elastic body that can be deformed by pressurization, a plate-like body that transmits an elastic force generated by the spring elastic body to the chemical solution storage section, and includes these along the inner wall of the exterior case. A pressure member that can move linearly,
The said pressurization member is equipped with the overhang | projection part which can contact | abut to the said lower clamping member at the time of the said additional injection | pouring, and can push this back back, The chemical | medical solution self-injection system characterized by the above-mentioned.
請求項2に記載の薬液自己注入システムにおいて、
前記加圧部材は、面対象あるいは点対象に配置された複数の係合部を備え、
前記上部挟持部材は、面対象あるいは点対称に配置された複数の係合突起を備え、
前記追加注入時に、前記係合部と前記係合突起とが係合できる構造を有していることを特徴とする薬液自己注入システム
The chemical liquid self-injection system according to claim 2,
The pressure member includes a plurality of engaging portions arranged on a surface object or a point object,
The upper clamping member includes a plurality of engaging protrusions arranged in plane or point symmetry,
The chemical liquid self-injection system has a structure that allows the engagement portion and the engagement protrusion to engage with each other during the additional injection.
請求項3に記載の薬液自己注入システムにおいて、
前記板状体は、前記薬液収納部の加圧変形が終了したときに、前記係合突起に作用して、前記係合部と前記係合突起による係合を解除するための係合解除突起を複数有していることを特徴とする薬液自己注入システム
In the chemical liquid self-injection system according to claim 3,
The plate-like body acts on the engagement protrusion when the pressure deformation of the chemical solution storage part is finished, and the engagement release protrusion for releasing the engagement by the engagement part and the engagement protrusion A chemical liquid self-injection system characterized by having a plurality.
JP2005304595A 2005-10-19 2005-10-19 Chemical self-injection system Active JP4898183B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005304595A JP4898183B2 (en) 2005-10-19 2005-10-19 Chemical self-injection system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005304595A JP4898183B2 (en) 2005-10-19 2005-10-19 Chemical self-injection system

Publications (2)

Publication Number Publication Date
JP2007111179A JP2007111179A (en) 2007-05-10
JP4898183B2 true JP4898183B2 (en) 2012-03-14

Family

ID=38093909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005304595A Active JP4898183B2 (en) 2005-10-19 2005-10-19 Chemical self-injection system

Country Status (1)

Country Link
JP (1) JP4898183B2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5517029B2 (en) * 2009-03-25 2014-06-11 ニプロ株式会社 Chemical self-injection device
WO2011075103A1 (en) 2009-12-16 2011-06-23 Becton, Dickinson And Company Self-injection device
JP5631603B2 (en) * 2010-02-05 2014-11-26 大研医器株式会社 Injection tool and chemical injection system equipped with the same
WO2012059454A1 (en) * 2010-11-03 2012-05-10 Sanofi-Aventis Deutschland Gmbh Medicated module for a drug delivery device
US8308688B2 (en) * 2010-12-15 2012-11-13 Kimberly-Clark Worldwide, Inc Large-volume bolus patient controlled drug administration device
US9061100B2 (en) 2013-10-11 2015-06-23 Avent, Inc. Large-volume bolus patient controlled drug administration device with lock-out
JP6222562B2 (en) * 2013-12-24 2017-11-01 オーベクス株式会社 Chemical liquid injection device and chemical liquid injection system including the same
JP7187908B2 (en) * 2018-09-13 2022-12-13 ニプロ株式会社 Chemical solution administration device and chemical injection controller used for the chemical solution administration device
DE102019200563A1 (en) * 2019-01-17 2020-07-23 Lts Lohmann Therapie-Systeme Ag Applicator
JP7185848B2 (en) * 2019-03-13 2022-12-08 ニプロ株式会社 chemical injection controller

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231371B1 (en) * 1985-08-06 1993-02-17 BAXTER INTERNATIONAL INC. (a Delaware corporation) Patient-controlled delivery of beneficial agents
JP3208759B2 (en) * 1997-03-18 2001-09-17 ニプロ株式会社 Chemical self-injection tool
JP3721777B2 (en) * 1998-03-17 2005-11-30 ニプロ株式会社 Chemical solution self-injection set
US6936035B2 (en) * 2002-12-31 2005-08-30 I-Flow Corporation Patient controlled drug administration device

Also Published As

Publication number Publication date
JP2007111179A (en) 2007-05-10

Similar Documents

Publication Publication Date Title
JP4898183B2 (en) Chemical self-injection system
US8720496B2 (en) Device, kit, and method for filling a flexible reservoir container in a negative pressure chamber
US10980546B2 (en) Hemostatic device
US5222948A (en) Injection port for single-use syringe
CN108697852B (en) Cover body and liquid medicine injection device with same
US20070276323A9 (en) Device and method for controlled expression of gases from medical fluids delivery systems
JPWO2018056050A1 (en) Chemical solution filling apparatus and chemical solution filling method
ES2862318T3 (en) Liquid medicine injection device capable of injecting additional liquid after completion of the injection of a liquid medicine
JP6222562B2 (en) Chemical liquid injection device and chemical liquid injection system including the same
JP4539382B2 (en) Patient controlled analgesia (PCA) device with continuous infusion and additional administration
JPH11164885A (en) Continuous drug solution injector
WO2003075986A1 (en) Recovering implement
JP2022168261A (en) Medical solution injector
KR20210030952A (en) Drug delivery system
WO2007122959A1 (en) Indwelling needle assembly
EP3812000A1 (en) End cap of liquid medicine injecting tube
KR20130038841A (en) Gas-pressured medication delivery device
JP3147346B2 (en) Chemical self-injection tool
JP3721777B2 (en) Chemical solution self-injection set
JP2725557B2 (en) Chemical injection device
JP2019154982A (en) Medicine administration device
JP2637579B2 (en) Balloon infuser
JPH1094602A (en) Syringe
JPH067722Y2 (en) Continuous drug infusion device with bellows container
KR20230086160A (en) Disposable syringe with hypodermic needle puncture prevention function

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20061228

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070816

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080922

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110510

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110616

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111220

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111226

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4898183

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150106

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250